Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:01 PM
Ignite Modification Date:
2025-12-24 @ 2:01 PM
NCT ID:
NCT00221195
Eligibility Criteria:
Inclusion Criteria:
* hemophilia A, any severity, with documented history of high-titer inhibitor (\>5BU); current use of bypassing agents (PCCs, aPCCs or rFVIIa) for treatment of bleeds; \>/= 6 bleeds requiring bypassing therapy in the previous 6 months
Exclusion Criteria:
* concomitant immune tolerance therapy; clinically symptomatic liver disease, platelet count less than 100,000
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
24 Months
Study:
NCT00221195
Study Brief:
Protocol Section:
NCT00221195